Biogen Inc.
Location
Massachusetts
Founded
1978-02-28
Website
Risk Signals
2647 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, Biological Products, Except Diagnostic Substances, Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Biogen Inc.
Live alerts from global media, monitored by Business Radar
2025-02-19 (tec.mx)
The knowledge economy: the engine that drives global transformation
Discover how Mexico is moving towards a knowledge economy, promoting innovation and technological development. Be part of this change
Read more
2025-02-19 (thebionews.net)
Global pharmaceutical company January acquisition. J & J · GSK · Lily Deal, Biogen and Posun Musan <Technology Transfer · Investment · IPO <Article Text-
[The Bio Yu -eun reporter] The global pharmaceutical industry has been mixed with the achievement of January. During the opening period of the 43rd JP Morgan Healthcare Conference 2025 (hereinafter referred to as JP Morgan), the world's largest bio investment event, the news of M & A of multinational pharmaceutical company Johnson and Johnson (J & J) is delivered.
Read more
2025-01-24 (mmm-online.com)
Rx Rundown: AbbVie, Purdue Pharma, HHS and more - MM+M - Medical Marketing and Media
Check out this week’s medical marketing news, dealmaking and industry chatter.
Read more
2025-01-20 (edisongroup.com)
BB Biotech — A positive start to a promising year -
BB Biotech (BION) is the largest biotech investor among its investment company peers.
Read more
2025-01-16 (marketbeat.com)
Czech National Bank Acquires 1,923 Shares of Biogen Inc. (NASDAQ:BIIB)
Czech National Bank boosted its position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 6.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 31,595 shares of the biotechnology company's stock after acquiring
Read more
2025-01-13 (defenseworld.net)
GAMMA Investing LLC Decreases Position in Biogen Inc. (NASDAQ:BIIB) -
Read GAMMA Investing LLC Decreases Position in Biogen Inc. (NASDAQ:BIIB) at Defense World
Read more
2025-01-08 (marketbeat.com)
Farmers Trust Co. Acquires New Position in Biogen Inc. (NASDAQ:BIIB)
Farmers Trust Co. purchased a new position in Biogen Inc. (NASDAQ:BIIB - Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 12,849 shares of the biotechnology company's stock, valued at approximately $1,965,000.
Read more
2024-12-15 (marketbeat.com)
Quantinno Capital Management LP Lowers Stock Holdings in Biogen Inc. (NASDAQ:BIIB)
Quantinno Capital Management LP lowered its stake in Biogen Inc. (NASDAQ:BIIB - Free Report) by 62.8% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,069 shares of the biotechnology company's stock after selling 5,172
Read more
2024-12-13 (marketbeat.com)
Inspire Trust Co. N.A. Grows Stock Holdings in Biogen Inc. (NASDAQ:BIIB)
Inspire Trust Co. N.A. grew its stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 58.5% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 10,900 shares of the biotechnology company's stock after buying an additional 4,0
Read more